Disease-Modifying Drug Treatment Before, During, and After Pregnancy in Women With MSJuly 27, 2017Multiple Sclerosis
When Should Neurologists Discontinue Disease-Modifying Treatments in Patients With MS?June 22, 2017Multiple Sclerosis
Study sheds light on pregnancy outcomes following ocrelizumab treatmentJune 14, 2017Multiple Sclerosis
Alemtuzumab May Prevent MRI Lesions for Six Years in Patients With Highly Active DiseaseMay 31, 2017Multiple Sclerosis
